|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 55 studies with search of: | Open Studies | "Spondylitis, Ankylosing" |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Progression of Spinal Fusion in Ankylosing Spondylitis
|
||||
| 2 | Recruiting |
Clinical and Radiographic Correlation of Ultrasound MASEI Index in Patients With Ankylosing Spondylitis
|
||||
| 3 | Recruiting |
A Study to Investigate the Use of Simponi® in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
|
||||
| 4 | Recruiting |
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)
|
||||
| 5 | Unknown † |
Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker
|
||||
| 6 | Unknown † |
Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis
|
||||
| 7 | Unknown † |
Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis
|
||||
| 8 | Unknown † |
Open Label Clinical Trial With Rituximab (MabThera ®) in Ankylosing Spondylitis
|
||||
| 9 | Recruiting |
Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Ankylosing Spondylitis
|
||||
| 10 | Recruiting |
Biologic Rheumatology Registry Across Canada
|
||||
| 11 | Recruiting |
Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
|
||||
| 12 | Not yet recruiting |
Effects of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) on RAdiographic Damage in Ankylosing Spondylitis
|
||||
| 13 | Unknown † |
Prednisolone in Active Ankylosing Spondylitis (AS)
|
||||
| 14 | Not yet recruiting |
European Ankylosing Spondylitis Infliximab Cohort (EASIC) Follow up Registration Study
|
||||
| 15 | Recruiting |
Special Investigation in Patients With Ankylosing Spondylitis (All Patients Investigation)
|
||||
| 16 | Recruiting |
Safety and Effectiveness of Adalimumab (Humira) in Patients With Ankylosing Spondylitis in Clinical Routine
|
||||
| 17 | Recruiting |
Efficacy at 16 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Ankylosing Spondylitis (AS)
|
||||
| 18 | Recruiting |
Multi-country Post-Marketing Observational Study on Maintenance of Effectiveness of Adalimumab (Humira®) in Patients With Ankylosing Spondylitis and Psoriatic Arthritis
|
||||
| 19 | Unknown † |
Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan
|
||||
| 20 | Not yet recruiting |
Prevalence Study of Gastrointestinal Risk Factors in Patients With Osteoarthritis (OA), Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS).
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|